Garofalo Health Care S.p.A. (BIT:GHC)
Italy · Delayed Price · Currency is EUR 5.30
+0.12 (2.32%)
At close: Oct 16, 2026
Garofalo Health Care Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 469 | 494 | 484 | 411 | 327 | 491 | |
Market Cap Growth | 2.23% | 2.11% | 17.65% | 25.54% | -33.34% | 13.32% |
Enterprise Value | 710 | 710 | 706 | 544 | 440 | 629 |
Last Close Price | 5.18 | 5.49 | 5.28 | 4.48 | 3.56 | 5.31 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.61 | 21.09 | 22.28 | 19.76 | 15.28 | 26.08 |
Forward PE | 18.76 | 17.52 | 18.18 | 16.28 | 13.12 | 20.37 |
PS Ratio | 0.93 | 1.02 | 1.03 | 1.12 | 1.02 | 1.74 |
PB Ratio | 1.28 | 1.41 | 1.45 | 1.37 | 1.17 | 1.88 |
P/FCF Ratio | 29.97 | 27.24 | 28.95 | 11.89 | 10.90 | 37.45 |
P/OCF Ratio | 8.30 | 10.07 | 13.82 | 8.22 | 7.46 | 13.53 |
PEG Ratio | - | 1.28 | 1.28 | 1.28 | 1.28 | 1.85 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.42 | 1.46 | 1.51 | 1.49 | 1.38 | 2.22 |
EV/EBITDA Ratio | 8.76 | 9.13 | 9.11 | 8.41 | 8.14 | 13.07 |
EV/EBIT Ratio | 12.86 | 13.04 | 13.52 | 12.59 | 12.33 | 19.30 |
EV/FCF Ratio | 45.79 | 39.15 | 42.26 | 15.73 | 14.67 | 47.94 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.68 | 0.64 | 0.69 | 0.85 | 0.63 | 0.70 |
Debt / EBITDA Ratio | 3.05 | 2.79 | 2.96 | 3.93 | 3.26 | 3.82 |
Debt / FCF Ratio | 15.91 | 12.44 | 13.74 | 7.36 | 5.87 | 14.00 |
Net Debt / Equity Ratio | 0.65 | 0.59 | 0.61 | 0.77 | 0.52 | 0.55 |
Net Debt / EBITDA Ratio | 3.01 | 2.64 | 2.62 | 3.58 | 2.68 | 2.96 |
Net Debt / FCF Ratio | 15.11 | 11.34 | 12.14 | 6.70 | 4.83 | 10.85 |
Asset Turnover | 0.56 | 0.57 | 0.57 | 0.51 | 0.50 | 0.52 |
Inventory Turnover | 61.48 | 62.02 | 63.13 | 58.24 | 58.69 | 56.97 |
Quick Ratio | 0.88 | 1.07 | 1.02 | 0.66 | 0.87 | 0.93 |
Current Ratio | 1.01 | 1.23 | 1.14 | 0.71 | 0.93 | 1.00 |
Return on Equity (ROE) | 5.49% | 6.90% | 6.89% | 7.20% | 7.94% | 8.12% |
Return on Assets (ROA) | 3.81% | 3.98% | 3.96% | 3.74% | 3.51% | 3.75% |
Return on Invested Capital (ROIC) | 5.88% | 6.44% | 6.44% | 6.51% | 6.76% | 6.85% |
Return on Capital Employed (ROCE) | 7.40% | 7.50% | 7.40% | 7.30% | 6.90% | 6.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.19% | 4.74% | 4.49% | 5.06% | 6.54% | 3.84% |
FCF Yield | 3.34% | 3.67% | 3.45% | 8.41% | 9.17% | 2.67% |
Dividend Yield | 1.75% | 1.66% | 1.57% | - | - | - |
Payout Ratio | 42.83% | 32.42% | - | - | - | - |
Buyback Yield / Dilution | 0.85% | 0.77% | -2.11% | 0.40% | 0.37% | -9.34% |
Total Shareholder Return | 2.64% | 2.43% | -0.54% | 0.40% | 0.37% | -9.34% |